Abstract

Muscle wasting is the most important phenotypic and clinical feature of cancer cachexia, and the principal cause of impaired physical function, fatigue, and respiratory complications. Muscle loss has been attributed to a variable combination of reduced nutritional intake and an imbalance between anabolic and catabolic processes. It has been suggested that defective skeletal muscle regeneration may also contribute to muscle wasting in cancer patients. However, there is little invitro or invivo data available, in either animals or in humans, regarding skeletal muscle regeneration in cancer wasting. The aim of the present review is to define the role of skeletal muscle regeneration in the muscle wasting of cancer patients and to determine possible therapeutic implications.
Original languageEnglish
Pages (from-to)522-527
Number of pages6
JournalCLINICAL AND EXPERIMENTAL PHARMACOLOGY & PHYSIOLOGY.
Volume43
Publication statusPublished - 2016

Keywords

  • MyoD
  • Necdin
  • Pax7
  • atrophy
  • cachexia
  • cancer
  • regeneration
  • skeletal muscle
  • wasting

Fingerprint

Dive into the research topics of 'Skeletal muscle regeneration in cancer cachexia'. Together they form a unique fingerprint.

Cite this